Pharmaceutical Department has recommended to the Department of Revenue a number of measures including hiking the benefit of weighted exemption to companies engaged in research and development with a view to scale up their overall spending in research activities in the country.

Seattle Genetics, Inc has entered into a worldwide collaboration agreement with Millennium: The Takeda Oncology Company, a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, for the development of antibody-drug conjugates (ADCs).

Eli Lilly has struck a drug discovery and research pact with India's Cadila Healthcare, the latest in a string of innovative R&D deals in the subcontinent.

NovaBay Pharmaceuticals, Inc, mid-stage biopharmaceutical company developing first-in-class anti-infective products for the treatment and prevention of a wide range of infections without causing resistance, has entered into an agreement with Galderma SA to develop and commercialize NovaBay's novel proprietary Aganocide compounds.